Sedivention

About Sedivention

Sedivention is a Munich-based MedTech company developing an outpatient, interventional weight-loss therapy. The team combines engineers and physicians to create a minimally invasive medical device that aims to reduce hunger signals via cryo-ablation, offering a one-time procedure with the goal of long-term appetite suppression. The therapy is positioned as a safe, office-based treatment for obesity and related health risks. The company highlights its milestones, clinical safety and efficacy testing, and collaborations with academic and industry partners.